AvePoint, Inc.AVPTNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank29
5Y CAGR-3.4%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-3.4%/yr
Long-term compound
Percentile
P29
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 7.98% |
| 2024 | 34.01% |
| 2023 | 15.88% |
| 2022 | -1.28% |
| 2021 | 160.28% |
| 2020 | 9.47% |
| 2019 | 35.23% |
| 2018 | 0.00% |